Synthesis of Sulindac

戴立言,李倩,贺电,王晓钟,陈英奇
DOI: https://doi.org/10.3321/j.issn:1003-9015.2009.04.022
2009-01-01
Abstract:Sulindac,a non-steroidal anti-inflammatory drug,has shown effectiveness in treating colonic polyps and inhibiting precancerous lesions. An improved synthetic process of producing sulindac was proposed. It starts from 4-fluorobenzyl chloride,via condensation with di-Et methylmalonate,hydrolysis in the present of KOH,decarboxylation,acid chlorination with SOCl2,intermolecular Friedel-Crafts reaction,condensation with cyanacetic acid,hydrolysis,condensation with p-methylthiobenzaldehyde and oxidation to yield sulindac. The effects of temperature,amount of catalysts and the ratio of substrate were investigated,and the suitable reaction conditions were obtained as follows:the decarboxylation temperature is 130~140℃; the mass ratio of anhydrous AlCl3 and 2-(4-fluorobenzyl)-2-methymaleic acid is 0.6:1 for the Friedel-Crafts reaction; the mass ratio of catalyst ammonium acetate and 6-fluoro-2-methylindanone is 0.1:1 for the condensation reaction between 6-fluoro-2 –methylindanone and cyanoacetic acid; the molar ratio of 5-fluoro-2-methylindanone-3-acetic acid,p-methylthiobenzaldehyde and sodium methoxide is 1:1:2.5~4.0 for the condensation reaction between 5-fluoro-2-methylindanone-3-acetic acid and p-methylthiobenzaldehyde; And the mass ratio of 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indenyl acetic acid and H2O2 is 1:0.15 for the oxidation reaction. The purities and structures of intermediates and products were examined by GC,GC-MS,IR and 1H-NMR.
What problem does this paper attempt to address?